In adults with HF with preserved ejection fraction and obesity, tirzepatide reduced a composite of CV death or worsening HF at 2 y
Year: 2025
Type: article
Source: Annals of Internal Medicine
Authors: Leslie A. Ynalvez, Anita Deswal
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409011940